Results 31 to 40 of about 10,304 (202)
Elevated vitreous Lipocalin-2 levels of patients with proliferative diabetic retinopathy
Background Lipocalin-2 (LCN2) is a novel adipokine with potential roles in obesity, insulin resistance, and inflammation. This study aims to assess the concentrations of LCN2 and vascular endothelial growth factor (VEGF) expressed in the vitreous humors ...
Hui Wang +6 more
doaj +1 more source
Fluorometric evaluation of panretinal photocoagulation in diabetic subjects [PDF]
ABSTRACTThe effect of panretinal photocoagulation on the blood‐retinal barrier was examined by long‐term kinetic vitreous fluorophotometry in eight insulin treated diabetic subjects, before and one month after unilateral panretinal photocoagulation. The fluorophotometric investigations revealed an increased permeability‐index following this treatment ...
L L, Knudsen, T, Olsen, F, Nielsen-Kudsk
openaire +2 more sources
Purpose: To evaluate contrast sensitivity in non-high-risk, treatment-naïve proliferative diabetic retinopathy patients treated with panretinal photocoagulation and intravitreal injections of ranibizumab) versus panretinal photocoagulation alone ...
Robert Hutnik (12436669) +10 more
core +1 more source
Entonox as an analgesic agent during panretinal photocoagulation [PDF]
Panretinal photocoagulation (PRP) reduces the risk of visual loss in proliferative diabetic retinopathy but some patients cannot tolerate PRP because of pain. Inhaled Entonox was evaluated as an analgesic during PRP.A randomised, crossover, double masked pilot study was performed. Patients inhaled either air or Entonox and half the PRP was applied. The
H L, Cook +5 more
openaire +2 more sources
Patient demographics before panretinal photocoagulation (at baseline).
Patient demographics before panretinal photocoagulation (at baseline).
Masahiro Akiba (724431) +7 more
core +1 more source
To compare panretinal photocoagulation (PRP) plus intravitreal bevacizumab (IVB) against PRP alone in the treatment of proliferative diabetic retinopathy (PDR) in terms of mean change in best corrected visual acuity (BCVA), neovessels on disc (NVD) and neovessels elsewhere (NVE).Experimental study.Department of Ophthalmology, Benazir Bhutto Hospital ...
Warda, Ali +2 more
openaire +2 more sources
ObjectiveThe objective of the study was to investigate the effectiveness of aflibercept and panretinal photocoagulation (PRP) in the treatment of proliferative diabetic retinopathy (PDR).MethodsA retrospective analysis was performed on 59 patients (59 ...
Hui Zhao +8 more
doaj +1 more source
Abstract Introduction The increasing number of patients with diabetes has increased the incidence of diabetic macular oedema (DME) with the accompanying risk of developing visual loss. The purpose of the present study was to describe the contributions of increased central retinal thickness (CRT) and other risk factors to the reduction in visual acuity ...
Signe Krejberg Jeppesen, Toke Bek
wiley +1 more source
Purpose: To evaluate the optical coherence tomography angiography (OCTA) parameters in patients with diabetic retinopathy following panretinal photocoagulation (PRP).
Ahmad Mirshahi +5 more
doaj +1 more source
Abstract Background Manual diabetic retinopathy (DR) grading may prefer certain regions and underestimate others. It is unclear if inexperienced graders' initial marking strategy reflects a specialist's marking pattern. Aims By the virtual ocular learning platform (VIOLA), we evaluated if initial DR‐lesion markings among inexperienced graders spatially
Simon Joel Ellerup Lowater +5 more
wiley +1 more source

